Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study.

Yoshida C, Yamaguchi H, Doki N, Murai K, Iino M, Hatta Y, Onizuka M, Yokose N, Fujimaki K, Hagihara M, Oshikawa G, Murayama K, Kumagai T, Kimura S, Najima Y, Iriyama N, Tsutsumi I, Oba K, Kojima H, Sakamaki H, Inokuchi K, Kanto CML Study Group

Open source

DOI: 10.1007/s12185-023-03549-3
Published: 2023 May
Container: International journal of hematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12185-023-03549-3,
  title = {Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study.},
  author = {Yoshida C and Yamaguchi H and Doki N and Murai K and Iino M and Hatta Y and Onizuka M and Yokose N and Fujimaki K and Hagihara M and Oshikawa G and Murayama K and Kumagai T and Kimura S and Najima Y and Iriyama N and Tsutsumi I and Oba K and Kojima H and Sakamaki H and Inokuchi K and Kanto CML Study Group},
  year = {2023},
  journal = {International journal of hematology},
  doi = {10.1007/s12185-023-03549-3},
  url = {https://doi.org/10.1007/s12185-023-03549-3}
}

RIS

TY  - JOUR
TI  - Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study.
AU  - Yoshida C
AU  - Yamaguchi H
AU  - Doki N
AU  - Murai K
AU  - Iino M
AU  - Hatta Y
AU  - Onizuka M
AU  - Yokose N
AU  - Fujimaki K
AU  - Hagihara M
AU  - Oshikawa G
AU  - Murayama K
AU  - Kumagai T
AU  - Kimura S
AU  - Najima Y
AU  - Iriyama N
AU  - Tsutsumi I
AU  - Oba K
AU  - Kojima H
AU  - Sakamaki H
AU  - Inokuchi K
AU  - Kanto CML Study Group
PY  - 2023
JO  - International journal of hematology
DO  - 10.1007/s12185-023-03549-3
UR  - https://doi.org/10.1007/s12185-023-03549-3
ER  -

APA

C, Y., H, Y., N, D., K, M., M, I., Y, H., M, O., N, Y., K, F., M, H., G, O., K, M., T, K., S, K., Y, N., N, I., I, T., K, O., H, K., H, S., K, I., & Group, K. C. S. (2023). Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study.. International journal of hematology. https://doi.org/10.1007/s12185-023-03549-3

Source records

pubmed · retrieved 2026-09-27T12:02:09.706Z